An announcement from Biotron Limited ( (AU:BIT) ) is now available.
Biotron Limited announced a change in the director’s interest notice for Michael J. Hoy, Michelle Miller, and Robert Thomas, as per the ASX Listing Rule 3.19A. The notice, approved by Managing Director Michelle Miller, details the acquisition of ordinary shares by Michael J. Hoy through a rights issue, doubling his holdings to 22,434,705 shares. This change reflects strategic financial maneuvers within the company, potentially impacting its market positioning and shareholder value.
More about Biotron Limited
Biotron Limited operates in the biotechnology industry, focusing on the development and commercialization of novel antiviral therapies. The company primarily targets viral diseases with significant unmet medical needs, leveraging its proprietary technology to develop drugs that inhibit viral replication.
YTD Price Performance: 390.0%
Average Trading Volume: 2,000
Technical Sentiment Signal: Sell
Current Market Cap: $4.33M
See more data about BIT stock on TipRanks’ Stock Analysis page.